Disease activity assessment in SLE: do we have the right instruments?
- 1 November 2007
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (Supplement), iii61-iii64
- https://doi.org/10.1136/ard.2007.078477
Abstract
No new therapy has been approved for systemic lupus erythematosus (SLE) in decades. Interest in SLE by pharmaceutical and biotechnology companies has increased, leading to multiple clinical trials. Unfortunately, we have now compiled quite a long list of "failed" trials. If this was due to the fact that the studied therapy did not work in SLE, we could accept it and move on. Of concern, however, is that many of the "failed" treatments had a strong "signal" of efficacy, often in subgroup analyses that made logical sense, given what was known about the mechanism of action of the treatment. This has led, understandably, to concern that there is something wrong with SLE trial designs, particularly with SLE disease activity indices.Keywords
This publication has 14 references indexed in Scilit:
- Combined Oral Contraceptives in Women with Systemic Lupus ErythematosusNew England Journal of Medicine, 2005
- Sequential Therapies for Proliferative Lupus NephritisNew England Journal of Medicine, 2004
- Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosusArthritis & Rheumatism, 2001
- Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.2001
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisNew England Journal of Medicine, 2000
- Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.2000
- Accurately describing changes in disease activity in Systemic Lupus Erythematosus.2000
- Patterns of disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1999
- Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus.Annals Of The Rheumatic Diseases, 1996
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusNew England Journal of Medicine, 1991